Cantor Fitzgerald Lowers its Price Target on Universal Health Services, Inc. (UHS) to $229 and Maintains a Neutral Rating

Universal Health Services, Inc. (NYSE:UHS) is among the 13 Most Undervalued S&P 500 Stocks to Invest In.

On February 27, 2026, Cantor Fitzgerald lowered its price target on Universal Health Services, Inc. (NYSE:UHS) to $229 from $250 and maintained a Neutral rating.

On February 26, 2026, BofA raised its price target on Universal Health Services, Inc. (NYSE:UHS) to $215 from $190 and kept an Underperform rating. The firm updated estimates with company guidance and introduced its 2028 view but reiterated Underperform, citing above-average exposure to policy changes and weak core results. The same day, Barclays increased its price target to $268 from $262 and maintained an Overweight rating following the Q4 report. Barclays said the company posted a modest miss as acute volumes decelerated but guided 2026 EBITDA ahead of Street estimates.

On February 25, 2026, Universal Health Services, Inc. (NYSE:UHS) reported Q4 EPS of $5.88 versus a consensus of $5.90 and revenue of $4.49 billion compared to $4.5 billion consensus. The company expects FY26 adjusted EPS of $22.64 to $24.52 versus consensus of $23.52 and FY26 revenue of $18.42 billion to $18.79 billion compared to $18.25 billion consensus.

Universal Health Services, Inc. (NYSE:UHS) owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities in the United States.

While we acknowledge the potential of UHS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026

Disclosure: None. Follow Insider Monkey on Google News.